Open access
Open access
Powered by Google Translator Translator

Archives

Beware survivorship bias in advice on science careers – “For objective careers advice, talk to those who left science as well as those who stayed”.

28 Sep, 2021 | 08:59h | UTC

Beware survivorship bias in advice on science careers – Nature

 


Review: Coronary artery anomalies.

28 Sep, 2021 | 09:02h | UTC

Coronary Artery Anomalies – Circulation (free for a limited period)

 

Commentary on Twitter

 


Review: Life-threatening skin conditions presenting to critical care.

28 Sep, 2021 | 08:57h | UTC

Life-threatening skin conditions presenting to critical care – BJA Education

 


New guidelines to improve reporting standards of studies that investigate causal mechanisms.

28 Sep, 2021 | 09:00h | UTC

News release: New guidelines to improve reporting standards of studies that investigate causal mechanisms – University of Oxford

Original article: A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement – JAMA (free for a limited period)

Commentary: Reporting Findings From Mediation Analyses – JAMA (free for a limited period)

 

Commentary on Twitter (thread – click for more)

 


Podcast: Diabetic Pearls.

28 Sep, 2021 | 08:53h | UTC

#296 Diabetes FAQ with Dr. Jeff Colburn – The Curbsiders

 


M-A of randomized trials: Efficacy of exercise combined with standard treatment for depression compared to standard treatment alone.

28 Sep, 2021 | 08:55h | UTC

Efficacy of exercise combined with standard treatment for depression compared to standard treatment alone: A systematic review and meta-analysis of randomized controlled trials – Journal of Affective Disorders

 

Commentary on Twitter

 


Interactive Infographic: Milestones in diabetes.

28 Sep, 2021 | 08:58h | UTC

Milestones in diabetes – Nature

 


Improving communication of incidental imaging findings: transforming uncertainty into opportunity.

28 Sep, 2021 | 08:50h | UTC

Improving Communication of Incidental Imaging Findings: Transforming Uncertainty Into Opportunity – Mayo Clinic Proceedings

Related:

Meta-Analysis: Incidental Findings on MRI of Apparently Asymptomatic Adults

Review: Prevalence and Outcomes of Incidental Imaging Findings

Study: Cascades of Care After Incidental Findings

 


Drug-resistant malaria is gaining a foothold in Africa – “Analyses of patient blood samples suggest artemisinin effectiveness is slipping”.

28 Sep, 2021 | 08:49h | UTC

Drug-resistant malaria is gaining a foothold in Africa – Science

 

Commentary on Twitter

 


Expert Analysis: How to do emergency action planning in sports.

28 Sep, 2021 | 08:52h | UTC

How To of Emergency Action Planning – American College of Cardiology

 

Commentary on Twitter

 


Podcast: Neutropenic Fever.

28 Sep, 2021 | 08:52h | UTC

#288 LIVE! Neutropenic Fever featuring Dr. Susan Seo – The Curbsiders

 


Updated WHO Living Guideline: Therapeutics and COVID-19.

26 Sep, 2021 | 22:16h | UTC

Therapeutics and COVID-19: living guideline – World Health Organization

WHO Statement: On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19

See also:

WHO recommends antibody treatment for COVID patients at high risk of hospital admission.

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis – The BMJ

Commentary: WHO adds new recommendation for COVID-19 monoclonal antibody combo – CIDRAP

 


[Preprint] More data showing longer dosing interval increases immune response after Pfizer-BioNTech’s COVID-19 vaccine.

26 Sep, 2021 | 22:15h | UTC

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses – medRxiv

Commentary: Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine – News Medical

Related:

[Preprint] Covid-19: Longer interval between Covid-19 Pfizer vaccine doses boosts immunity.

[Preprint] Delaying second Pfizer vaccine dose to 12 weeks increases specific antibody response 3.5-fold in people over 80 years of age.

Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval

 


In Gratitude for mRNA Vaccines.

26 Sep, 2021 | 22:13h | UTC

In Gratitude for mRNA Vaccines – New England Journal of Medicine

 


CDC Report: Schools without mask requirements were more likely to have Covid-19 outbreaks.

26 Sep, 2021 | 22:10h | UTC

Association Between K–12 School Mask Policies and School-Associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: Schools Without Mask Requirements More Likely to See COVID-19 Outbreaks – U.S. News

 

Commentary on Twitter

 


Graphic Perspective: Mask Wars.

26 Sep, 2021 | 22:12h | UTC

Mask Wars – New England Journal of Medicine

 


Opinion | Inappropriate Mixing Clinical and Systemic Thinking: Vaccines in the Young.

26 Sep, 2021 | 22:07h | UTC

Inappropriate Mixing Clinical and Systemic Thinking: Vaccines in the Young – Medium

 


Fraudulent ivermectin studies open up new battleground between science and misinformation.

26 Sep, 2021 | 22:08h | UTC

Fraudulent ivermectin studies open up new battleground between science and misinformation – The Guardian

 


Covid-19 Vaccines – Billions Committed, Millions Delivered.

26 Sep, 2021 | 22:05h | UTC

Billions Committed, Millions Delivered – Think Global Health

 

Commentary on Twitter

 


AUA/SMSNA Guideline: Acute Ischemic Priapism.

26 Sep, 2021 | 21:55h | UTC

Acute Ischemic Priapism: An AUA/SMSNA Guideline – The Journal of Urology

 


Consensus Statement: Paracetamol use during pregnancy — a call for precautionary action – “Pregnant women should minimize risk by using the lowest effective APAP dose for the shortest possible time”.

26 Sep, 2021 | 22:02h | UTC

Paracetamol use during pregnancy — a call for precautionary action – Nature Reviews Endocrinology

Editorial: Caution needed: paracetamol use in pregnancy – Nature Reviews Endocrinology

Commentaries:

New research cautions about possible risks of acetaminophen use during pregnancy – STAT

Expert reaction to statement on paracetamol use during pregnancy – Science Media Centre

A Common Pain Relief Med Used in Pregnancy Should Be Taken with Caution, Experts Warn – ScienceAlert

Scientists suggest pregnant women only take paracetamol/acetaminophen if medically necessary – MedicalXpress

 

Commentary on Twitter

 


Evaluating the Cost-effectiveness of Prehospital Plasma Transfusion in Unstable Trauma Patients: A Secondary Analysis of the PAMPer Trial.

26 Sep, 2021 | 21:54h | UTC

Evaluating the Cost-effectiveness of Prehospital Plasma Transfusion in Unstable Trauma Patients: A Secondary Analysis of the PAMPer Trial – JAMA Surgery (free for a limited period)

Commentaries:

CHEERS to You on a Well-done Cost-effectiveness Analysis of Prehospital Plasma for Helicopter Resuscitation of Patients With Traumatic Shock – JAMA Surgery (free for a limited period)

Prehospital Plasma: A Cheap, Effective Way to Save Trauma Patients’ Lives? – BreakingMed

 

Commentary on Twitter

 


Clinical Review on the Management of Metastatic Renal Cell Carcinoma.

26 Sep, 2021 | 21:41h | UTC

Clinical Review on the Management of Metastatic Renal Cell Carcinoma – JCO Oncology Practice

 


The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction.

26 Sep, 2021 | 21:58h | UTC

The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction – The Journal of Urology

Part I: Diagnosis and Evaluation – The Journal of Urology

Part II: Treatment and Follow up – The Journal of Urology

 


RCT: Pembrolizumab for persistent, recurrent, or metastatic cervical cancer.

26 Sep, 2021 | 21:43h | UTC

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer – New England Journal of Medicine

Commentary: KEYNOTE-826: Pembrolizumab Plus Chemotherapy in Advanced Cervical Cancer – The ASCO Post

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.